Sarepta Therapeutics, Inc. (SRPT)
18.13
-0.66
(-3.51%)
USD |
NASDAQ |
Aug 24, 16:00
18.13
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Total Liabilities (Quarterly) : 1.661B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.661B |
| March 31, 2026 | 1.674B |
| December 31, 2025 | 2.209B |
| September 30, 2025 | 2.173B |
| June 30, 2025 | 2.322B |
| March 31, 2025 | 2.323B |
| December 31, 2024 | 2.435B |
| September 30, 2024 | 2.379B |
| June 30, 2024 | 2.347B |
| March 31, 2024 | 2.263B |
| December 31, 2023 | 2.405B |
| September 30, 2023 | 2.345B |
| June 30, 2023 | 2.384B |
| March 31, 2023 | 2.347B |
| December 31, 2022 | 2.743B |
| September 30, 2022 | 2.725B |
| June 30, 2022 | 2.270B |
| March 31, 2022 | 2.199B |
| December 31, 2021 | 2.220B |
| September 30, 2021 | 2.193B |
| June 30, 2021 | 2.274B |
| March 31, 2021 | 2.230B |
| December 31, 2020 | 2.223B |
| September 30, 2020 | 1.889B |
| June 30, 2020 | 1.840B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.803B |
| December 31, 2019 | 1.005B |
| September 30, 2019 | 707.27M |
| June 30, 2019 | 648.59M |
| March 31, 2019 | 615.33M |
| December 31, 2018 | 609.80M |
| September 30, 2018 | 543.06M |
| June 30, 2018 | 548.11M |
| March 31, 2018 | 523.52M |
| December 31, 2017 | 518.75M |
| September 30, 2017 | 103.12M |
| June 30, 2017 | 72.37M |
| March 31, 2017 | 82.39M |
| December 31, 2016 | 87.41M |
| September 30, 2016 | 78.69M |
| June 30, 2016 | 82.61M |
| March 31, 2016 | 74.40M |
| December 31, 2015 | 83.44M |
| September 30, 2015 | 61.52M |
| June 30, 2015 | 66.33M |
| March 31, 2015 | 41.95M |
| December 31, 2014 | 47.38M |
| September 30, 2014 | 32.85M |
| June 30, 2014 | 37.39M |
| March 31, 2014 | 46.43M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Moderna, Inc. | 4.20B |
| ImmunityBio, Inc. | 1.674B |
| X4 Pharmaceuticals, Inc. | 97.61M |
| MapLight Therapeutics, Inc. | 20.05M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.189B |
| Shareholders Equity (Quarterly) | 1.528B |
| Debt to Equity Ratio | 0.6845 |
| Current Ratio | 4.422 |
| Net Debt Paydown Yield | 3.14% |